The involvement of anterior gradient 2 in the stromal cell-derived factor 1-induced epithelial-mesenchymal transition of glioblastoma

Tumor Biology

Volumn 37, Issue 5, 2016, Pages 6091-6097

  Xu, Chunhua ^a   Liu, Yue ^a   Xiao, Limin ^a   Guo, Changgui ^a   Deng, Shengze ^a   Zheng, Suyue ^a   Zeng, Erming ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

AGR2; EMT; Glioblastoma; SDF 1

Indexed keywords

ANTERIOR GRADIENT 2 PROTEIN; CHEMOKINE RECEPTOR CXCR4; GELATINASE A; NERVE CELL ADHESION MOLECULE; PROTEIN KINASE B; REGULATOR PROTEIN; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR SLUG; UNCLASSIFIED DRUG; AGR2 PROTEIN, HUMAN; CXCL12 PROTEIN, HUMAN; MESSENGER RNA; PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CELL CYCLE ARREST; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; CELL CYCLE; CELL MOTION; GENE EXPRESSION; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL12; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GLIOBLASTOMA; HUMANS; PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CXCR4; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84948150172     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4481-0     Document Type: Article

References (23)

1. Kirkpatrick JP, Sampson JH. Recurrent malignant gliomas. Semin Radiat Oncol. 2014;24:289–98.
2. Young RM, Jamshidi A, Davis G, et al. Current trends in the surgical management and treatment of adult glioblastoma. Ann Transl Med. 2015;3:121.
3. Wilson TA, Karajannis MA, Harter DH. Glioblastoma multiforme: state of the art and future therapeutics. Surg Neurol Int. 2014;5:64.
4. Weathers SP, Gilbert MR. Advances in treating glioblastoma. F1000Prime Rep. 2014;6:46.
5. Lv B, Yang X, Lv S, Wang L, et al. CXCR4 signaling induced epithelial-mesenchymal transition by PI3K/AKT and ERK pathways in glioblastoma. Mol Neurobiol. 2015;52(3):1263–8.
6. Dai C, Lv S, Shi R, et al. Nuclear protein C23 on the cell surface plays an important role in activation of CXCR4 signaling in glioblastoma. Mol Neurobiol. 2015;52(3):1521–6.
7. Ehling J, Tacke F. Role of chemokine pathways in hepatobiliary cancer. Cancer Lett. 2015. doi:10.1016/j.canlet.2015.06.017.
8. Stoicov C, Li H, Liu JH, et al. Mesenchymal stem cells utilize CXCR4-SDF-1 signaling for acute, but not chronic, trafficking to gastric mucosal inflammation. Dig Dis Sci. 2013;58:2466–77.
9. Kuang WW, Thompson DA, Hoch RV, et al. Diferential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acids Res. 1998;26:1116–23.
10. Thompson DA, Weigel RJ. hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. Biochem Biophys Res Commun. 1998;251:111–6.
11. Fletcher GC, Patel S, Tyson K, et al. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br J Cancer. 2003;88:579–85.
12. Niu H, Zhang X, Wang B, et al. The clinical utility of RFA in esophageal and cardia cancer patients with severe malignant obstruction. Tumour Biol. 2015. doi:10.1007/s13277-015-3925-x
13. Lv S, Sun B, Zhong X, et al. The clinical implications of chemokine receptor CXCR4 in grade and prognosis of glioma patients: a meta-analysis. Mol Neurobiol. 2015;52(1):555–61.
14. Tidball JG, Welc SS. Macrophage-derived IGF-1 is a potent coordinator of myogenesis and inflammation in regenerating muscle. Mol Ther. 2015;23:1134–5.
15. Du J, Li B, Fang Y, et al. Overexpression of class III β-tubulin, Sox2, and nuclear survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer. BMC Cancer. 2015;15:536.
16. Ramakrishna R, Pisapia D. Recent molecular advances in our understanding of glioma. Cureus. 2015;7:e287.
17. Bhuvanalakshmi G, Arfuso F, Millward M, et al. Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties. PLoS One. 2015;10:e0127517.
18. Zhang B, Shi L, Lu S, et al. Autocrine IL-8 promotes F-actin polymerization and mediate mesenchymal transition via ELMO1-NF-κB-Snail signaling in glioma. Cancer Biol Ther. 2015;16:898–911.
19. Palena C, Hamilton DH, Fernando RI. Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment. Future Oncol. 2012;8:713–22.
20. Pan Y, Zhang Y, Chen L, et al. The critical role of Rab31 in cell proliferation and apoptosis in cancer progression. Mol Neurobiol. 2015. doi:10.1007/s12035-015-9378-9
21. Kim YS, Joh TH. Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders. Biomol Ther (Seoul). 2012;20:133–43.
22. Yan J, Zhang Y, Shi W, et al. The critical role of HMGA2 in regulation of EMT in epithelial ovarian carcinomas. Tumour Biol. 2015. doi:10.1007/s13277-015-3852-x
23. Yang X, Lv S, Liu Y, et al. The clinical utility of matrix metalloproteinase 9 in evaluating pathological grade and prognosis of glioma patients: a meta-analysis. Mol Neurobiol. 2015;52(1):38–44.